Ron Kocak

CIK: 0002011160

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RNXT

RenovoRx, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

RNXT
RenovoRx, Inc.
Jul 1, 2025
Award(A)
Stock Option
Direct
41.6K shares-
RNXT
RenovoRx, Inc.
Apr 14, 2025
Award(A)
Stock Option
Direct
166.4K shares-
RNXT
RenovoRx, Inc.
Apr 10, 2025
Purchase(P)
Direct
6.5K shares at avg. $0.79$5K
RNXT
RenovoRx, Inc.
Apr 9, 2025
Purchase(P)
Direct
6K shares at avg. $0.80$5K
RNXT
RenovoRx, Inc.
Apr 8, 2025
Purchase(P)
Direct
95 shares at avg. $0.80$76

		Type	Shares	Price		Ownership
Jul 1, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Option	41,600	-	-	Direct
Apr 14, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Option	166,400	-	-	Direct
Apr 10, 2025	RNXT RenovoRx, Inc.	Purchase(P)	6,500	$0.79	$5,135	Direct
Apr 9, 2025	RNXT RenovoRx, Inc.	Purchase(P)	6,000	$0.80	$4,800	Direct
Apr 8, 2025	RNXT RenovoRx, Inc.	Purchase(P)	95	$0.80	$76	Direct

1-5 of 5 transactions

About Kocak Ron

Kocak Ron (SEC CIK 0002011160) files insider reports with the SEC as VP Controller and PAO of RenovoRx, Inc. (RNXT).

Signal8 holds 3 ownership filings by Kocak Ron, all Form 4s, filed between Apr 10, 2025 and Jul 3, 2025. Those filings report 5 transactions, from Apr 8, 2025 to Jul 1, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Kocak Ron's filings is in MOUNTAIN VIEW, CA.

Recent filings by Kocak Ron

Jul 1, 2025: Grant or award of RNXT derivative securities (Form 4, code A).
Apr 14, 2025: Grant or award of RNXT derivative securities (Form 4, code A).
Apr 10, 2025: Open-market purchase of RNXT shares (Form 4, code P).
Apr 9, 2025: Open-market purchase of RNXT shares (Form 4, code P).
Apr 8, 2025: Open-market purchase of RNXT shares (Form 4, code P).

Other insiders filing for RenovoRx, Inc. (RNXT)

Macfarlane K. Angela, Director
Spiegel Robert J., Director
RYAN UNA S, Director
Marton Laurence, Director
VOLL MARK, Chief Financial Officer
Bagai Shaun, Chief Executive Officer

How to read Form 4 transaction codes